✦ LIBER ✦

NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer

✍ Scribed by Klaus Sahora; Irene Kuehrer; Axel Eisenhut; Belgin Akan; Claus Koellblinger; Peter Goetzinger; Bela Teleky; Raimund Jakesz; Markus Peck-Radosavljevic; Ahmed Ba’ssalamah; Christoph Zielinski; Michael Gnant

Book ID: 113921611
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 311 KB
Volume: 149
Category: Article
ISSN: 0039-6060
DOI: 10.1016/j.surg.2010.07.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NeoGemTax: Gemcitabine and Docetaxel as

NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer

✍ Klaus Sahora; Irene Kuehrer; Martin Schindl; Claus Koelblinger; Peter Goetzinger 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 226 KB

Neoadjuvant chemoradiation with Gemcitab

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

✍ Daniel Habermehl, Kerstin Kessel, Thomas Welzel, Holger Hof… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 359 KB

Hypofractionated Chemoradiation Therapy

Hypofractionated Chemoradiation Therapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally-Advanced Pancreatic Cancer

✍ Romeo, A.; Parisi, E.; Passardi, A.; Bellia, S.; Arpa, D.; Ghigi, G.; Neri, E.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Concurrent gemcitabine and radiotherapy

Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

✍ Mustafa Cengiz; Faruk Zorlu; Suayip Yalcin; Murat Gurkaynak; I. Lale Atahan; Ibr 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 59 KB

Gemcitabine and oxaliplatin combination

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

✍ Kyung Hee Lee; Min Kyoung Kim; Yeol Hong Kim; Baek Yeol Ryoo; Ho Yeong Lim; Hong 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 341 KB

Gemcitabine-based neoadjuvant chemothera

Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection

✍ K. Sahora MD, M. Schindl MD, I. Kuehrer MD, G. Werba MD, F. Fitzal MD, P. Goetzi 📂 Article 📅 2013 🏛 Blackwell Publishing 🌐 German ⚖ 815 KB